Big Breakthrough Drug for Regeneron
The FDA’s approval this week of a new drug to treat eczema and other skin conditions is being hailed by experts as a huge money maker for Regeneron and its French partner Sanofi.
The FDA approval of Dupixent announced Monday is a breakthrough for Regeneron. Unlike other topical and oral medications used to treat skin conditions, Dupixent is injectable and said to be more effective in treating chronic conditions. The new drug is expected to be a blockbuster for the company with an estimated $3 billion in annual sales.
“This is wonderful news for Regeneron and for Westchester,’’ said Marsha Gordon, President and CEO of the Business Council of Westchester. “Regeneron is at the core of Westchester’s budding Life Sciences/BioTech Industry and its continued success can only bode well for this business sector.’’ Regeneron announced in September plans to double the size of its Westchester headquarters.
Similar News Items
CLICK HERE to watch An Experiential Economy: The Transformation of Retail & Hospitality.
In big news on the retail front, announced at Wednesday’s Business Council of Westchester and Fordham University Real Estate Institute event, BCW Member Marx Realty announced this week it has begun construction on a two-building, 58,000-square-foot retail expansion at Cross County Center in Yonkers. The 1.15 million-square-foot retail center is now home to over 100 […]
RYE BROOK, NY – The digital transformation of Westchester County’s small business landscape took a significant leap forward on Tuesday as The Business Council of Westchester (BCW) launched the first session of its “AI Intensive 2026.” Supported by Google.org, the groundbreaking professional development program aims to provide local enterprises with the tools and expertise necessary […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.